# US 2004/0203069 A1 · Method for determining and/or isolating lipid-binding compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0203069 A1
- Document ID: US20040203069A1
- Status: Published application
- Kind: A1
- Application number: 10/410,684
- Filed: 2003-04-10
- Published: 2004-10-14
- Earliest claimed: 2003-04-10
- Inventors: Chris Reutelingsperger
- Web page: https://patentgrep.com/patent/US20040203069A1

## CPC

- G01N 33/92: involving lipids, e.g. cholesterol {, lipoproteins, or their receptors (steroid hormones G01N33/743)}
- G01N 2333/4718: Lipocortins
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention relates to a method for determining rapidly the biological activity of lipid-binding compounds, such as Annexins. The compounds may be are labeled. The labeled compounds are mixed with divalent cations and with a, particulate or other, carrier containing negatively charged phospholipids. The mixture is incubated and, subsequently, submitted to a procedure to separate the carrier from the solution. This separation procedure can involve for example a magnet, if (para)magnetic particles are used, a centrifugation step or a filtration through a filter, the pores of which are smaller than the particles. The distribution of label over the solution and the carrier reflects the portion of biologically active labeled compound. The presence of neutralizing factors in a sample can be measured by contacting the sample with a known amount of phospholipids on the career.

## Claims

### Claim 1

A method for determining the biologically active fraction from a mixture containing lipid-binding compounds in a liquid sample, the method comprising:
a: contacting the sample with a solid carrier crying lipids;
b: separating the solid lipid-carrying carrier from the liquid, and
c: determining the fraction bound to the separated carrier.

### Claim 2 (depends on 1)

A method according to claim 1, in which said carrier is in the form of particles.

### Claim 3 (depends on 2)

A method according to claim 2, in which said particles contain metal and/or metal oxides.

### Claim 4 (depends on 3)

A method according to claim 3, in which said particles have or can be induced to have magnetic properties.

### Claim 5 (depends on 3)

A method according to claim 3, in which said particles comprise a polymer selected from agarose, cellulose, collagen, dextran, polyacrylamide, polyvinyl, polyvinyl alcohol, polyethylene glycol, polystyrene and latex.

### Claim 6 (depends on 1)

A method according to claim 1, in which said lipids comprise one or more of phosphatidylserine, cardiolipin, phosphatidic acid, phosphatidylinositol, phosphatidyl-ethanolamine, phosphatidylcholine, sphingomyelin and cholesterol and their lyso analogs.

### Claim 7 (depends on 6)

A method according to claim 6, in which said lipids comprise phosphatidylserine.

### Claim 8 (depends on 1)

A method according to claim 1, in which the lipid-binding compounds are polypeptides.

### Claim 9 (depends on 8)

A method according to claim 8, in which the lipid-binding compounds comprise a member of the Annexin family, and said contacting step (a) is carried out in the presence of divalent cations.

### Claim 10

A method according to 1, in which at least one of the lipid-binding compounds is labeled with a radioactive tracer, a fluorescent probe or an antibody or part thereof.

### Claim 11 (depends on 1)

A kit for performing the method of claim 1, containing lipid-coated particles, said particles having or being inducible to have magnetic properties.

### Claim 12 (depends on 11)

A kit according to claim 11, further containing a magnet as a separator means.

### Claim 13

A method for determining the presence of compounds in a biological sample that neutralize the biological activity of lipid-binding proteins, the method comprising;
a: mixing the biological sample with a known amount of a lipid-binding protein; and
b: contacting the lipid-binding protein, before, during or after step a, with a solid carrier carrying lipids; and
c: separating the solid carrier carrying lipids with a separator from the liquid; and
d: determining the fraction of lipid-binding protein bound to the separated carrier.

### Claim 14 (depends on 13)

A method according to claim 13, in which said carrier is in the form of particles.

### Claim 15 (depends on 14)

A method according to claim 14, in which said particles contain metal and/or metal oxides.

### Claim 16 (depends on 15)

A method according to claim 15, in which said particles have or can be induced to have magnetic properties.

### Claim 17 (depends on 13)

A method according to claim 13, in which said lipids comprise phosphatidylserine.

### Claim 18 (depends on 13)

A method according to claim 13, in which a the lipid-binding compounds comprise a member of the Annexin family, and said contacting step (b) is carried out in the presence of divalent cations.

### Claim 19 (depends on 13)

A method according to claim 13, in which at least one of the lipid-binding compounds is labeled with a radioactive tracer, a fluorescent probe or an antibody or part thereof.

### Claim 20 (depends on 13)

A kit for performing the method of claim 13 containing
lipid-coated particles;
a lipid-binding protein.

### Claim 21 (depends on 20)

A kit according to claim 20, father containing divalent cations.
